These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38876301)

  • 21. HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.
    Gao W; Jia Z; Tian Y; Yang P; Sun H; Wang C; Ding Y; Zhang M; Zhang Y; Yang D; Tian Z; Zhou J; Ruan Z; Wu Y; Ni B
    Hepatology; 2020 May; 71(5):1678-1695. PubMed ID: 31544250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket.
    Song JJ; Kingston RE
    J Biol Chem; 2008 Dec; 283(50):35258-64. PubMed ID: 18840606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis for the specific recognition of methylated histone H3 lysine 4 by the WD-40 protein WDR5.
    Han Z; Guo L; Wang H; Shen Y; Deng XW; Chai J
    Mol Cell; 2006 Apr; 22(1):137-44. PubMed ID: 16600877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis of plant homeodomain finger 6 (PHF6) recognition by the retinoblastoma binding protein 4 (RBBP4) component of the nucleosome remodeling and deacetylase (NuRD) complex.
    Liu Z; Li F; Zhang B; Li S; Wu J; Shi Y
    J Biol Chem; 2015 Mar; 290(10):6630-8. PubMed ID: 25601084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for molecular recognition and presentation of histone H3 by WDR5.
    Schuetz A; Allali-Hassani A; Martín F; Loppnau P; Vedadi M; Bochkarev A; Plotnikov AN; Arrowsmith CH; Min J
    EMBO J; 2006 Sep; 25(18):4245-52. PubMed ID: 16946699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma.
    Han QL; Zhang XL; Ren PX; Mei LH; Lin WH; Wang L; Cao Y; Li K; Bai F
    Acta Pharmacol Sin; 2023 Apr; 44(4):877-887. PubMed ID: 36207403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction.
    Karatas H; Townsend EC; Bernard D; Dou Y; Wang S
    J Med Chem; 2010 Jul; 53(14):5179-85. PubMed ID: 20575550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction.
    Ding J; Liu L; Chiang YL; Zhao M; Liu H; Yang F; Shen L; Lin Y; Deng H; Gao J; Sage DR; West L; Llamas LA; Hao X; Kawatkar S; Li E; Jain RK; Tallarico JA; Canham SM; Wang H
    J Med Chem; 2023 Jun; 66(12):8310-8323. PubMed ID: 37307526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Progress in Modulation of WD40-Repeat Domain 5 Protein (WDR5): Inhibitors and Degraders.
    Gurung R; Om D; Pun R; Hyun S; Shin D
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and biochemical insights into MLL1 core complex assembly.
    Avdic V; Zhang P; Lanouette S; Groulx A; Tremblay V; Brunzelle J; Couture JF
    Structure; 2011 Jan; 19(1):101-8. PubMed ID: 21220120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular recognition of histone H3 by the WD40 protein WDR5.
    Couture JF; Collazo E; Trievel RC
    Nat Struct Mol Biol; 2006 Aug; 13(8):698-703. PubMed ID: 16829960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.
    Zhou Q; Chen X; He H; Peng S; Zhang Y; Zhang J; Cheng L; Liu S; Huang M; Xie R; Lin T; Huang J
    Theranostics; 2021; 11(10):4809-4824. PubMed ID: 33754029
    [No Abstract]   [Full Text] [Related]  

  • 33. Disentangling the recognition complexity of a protein hub using a nanopore.
    Mayse LA; Imran A; Larimi MG; Cosgrove MS; Wolfe AJ; Movileanu L
    Nat Commun; 2022 Feb; 13(1):978. PubMed ID: 35190547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC.
    Thomas LR; Wang Q; Grieb BC; Phan J; Foshage AM; Sun Q; Olejniczak ET; Clark T; Dey S; Lorey S; Alicie B; Howard GC; Cawthon B; Ess KC; Eischen CM; Zhao Z; Fesik SW; Tansey WP
    Mol Cell; 2015 May; 58(3):440-52. PubMed ID: 25818646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Two Distinct Nucleosome Remodeling and Deacetylase (NuRD) Complex Assemblies in Embryonic Stem Cells.
    Bode D; Yu L; Tate P; Pardo M; Choudhary J
    Mol Cell Proteomics; 2016 Mar; 15(3):878-91. PubMed ID: 26714524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.
    Ivanochko D; Halabelian L; Henderson E; Savitsky P; Jain H; Marcon E; Duan S; Hutchinson A; Seitova A; Barsyte-Lovejoy D; Filippakopoulos P; Greenblatt J; Lima-Fernandes E; Arrowsmith CH
    Nucleic Acids Res; 2019 Feb; 47(3):1225-1238. PubMed ID: 30462309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragment screening for a protein-protein interaction inhibitor to WDR5.
    Dennis ML; Morrow BJ; Dolezal O; Cuzzupe AN; Stupple AE; Newman J; Bentley J; Hattarki M; Nuttall SD; Foitzik RC; Street IP; Stupple PA; Monahan BJ; Peat TS
    Struct Dyn; 2019 Nov; 6(6):064701. PubMed ID: 31768400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a novel WDR5-binding site that recruits RbBP5 through a conserved motif to enhance methylation of histone H3 lysine 4 by mixed lineage leukemia protein-1.
    Odho Z; Southall SM; Wilson JR
    J Biol Chem; 2010 Oct; 285(43):32967-32976. PubMed ID: 20716525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways.
    Chen T; Li K; Liu Z; Liu J; Wang Y; Sun R; Li Z; Qiu B; Zhang X; Ren G; Xu Y; Zhang Z
    Mol Ther; 2021 Jun; 29(6):2134-2150. PubMed ID: 33601056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. METTL3 orchestrates glycolysis by stabilizing the c-Myc/WDR5 complex in triple-negative breast cancer.
    Yuan XN; Shao YC; Guan XQ; Liu Q; Chu MF; Yang ZL; Li H; Zhao S; Tian YH; Zhang JW; Wei L
    Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119716. PubMed ID: 38547933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.